Basit öğe kaydını göster

dc.contributor.authorÖzdilli, Kürşat
dc.contributor.authorBekerecioğlu, Mehmet
dc.contributor.authorNursal, Ayşe Feyda
dc.contributor.authorPehlivan, Mustafa
dc.contributor.authorSever, Ülgen
dc.contributor.authorBüyükgüral, Berker
dc.contributor.authorPehlivan, Sacide
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:50:19Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T19:50:19Z
dc.date.issued2018en_US
dc.identifier.citationÖzdilli, K., Bekerecioğlu, M., Nursal, A., Pehlivan, M., Sever, Ü., Büyükgüral, B. ... Pehlivan, S. (2018). Do UCP2, IL-17, mi196a2, and NR3C1 gene variants contribute to the risk of microtia? A preliminary study in Turkish population. European Biotechnology Congress içinde (S21-S21. ss.). Athens, Greece, April 26-28, 2018. https://dx.doi.org/10.1016/j.jbiotec.2018.06.064en_US
dc.identifier.issn0168-1656
dc.identifier.issn1873-4863
dc.identifier.urihttps://dx.doi.org/10.1016/j.jbiotec.2018.06.064
dc.identifier.urihttps://hdl.handle.net/20.500.12511/1948
dc.descriptionEuropean Biotechnology Congress -- APR 26-28, 2018 -- Athens, GREECEen_US
dc.descriptionWOS: 000454825900062en_US
dc.description.abstractMicrotia is a congenital malformation of variable severity of theexternal and middle ear. Although many genetic and environmen-tal factors are investigated the etiopathogenesis of microtia, it isstill uncertain. We performed case–control analysis to assess theeffect of UCP2−866 G/A, IL-17−7488 A/G, miR196a2 T/C, NR3C1Bcl1 variants on the risk of microtia. This study includes 18 microtiapatients and 70 healthy controls. The functional variants of UCP2,IL-17, miR196a2, andNR3C1genes were evaluated using PCR-RFLPmethod. The frequencies of the alleles and genotypes in groupswere compared by the 2test A significant difference was foundbetween the control group and the patients as for genotype andallele frequencies of NR3C1 Bcl1 variant. No significant differencewas found in the distribution of genotypes and alleles frequen-cies between patients and healthy controls for UCP2, IL-17, andmiR196a2 variants (p> 0.05). To our knowledge, this is the firststudy to evaluate relationship between these gene variants andmicrotia risk in a Turkish cohort. Our results suggest that theNR3C1Bcl1 variant might reflect the risk of microtia in a Turkish popula-tion. Further studies in larger populations are required to achievea definitive conclusion.en_US
dc.language.isoengen_US
dc.publisherElsevier Science Bven_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleDo UCP2, IL-17, mi196a2, and NR3C1 gene variants contribute to the risk of microtia? A preliminary study in Turkish populationen_US
dc.typeconferenceObjecten_US
dc.relation.ispartofEuropean Biotechnology Congressen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalıen_US
dc.authorid0000-0002-7129-5024en_US
dc.identifier.volume280en_US
dc.identifier.issueSupplement: Sen_US
dc.identifier.startpageS21en_US
dc.identifier.endpageS21en_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1016/j.jbiotec.2018.06.064en_US
dc.identifier.wosqualityQ2en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster